Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Denmark Danish Medicines Agency approves medical cannabis oil product ...
  • Ohio - United States Bill to ban sale of intoxicating hemp products unlikely to move forward ...
  • Europe European Council adopts regulation to reduce and recycle packaging ...
  • Germany Two Berlin districts to start recreational cannabis sales ...
  • Nebraska - United States Two cannabis measures signed into law ...
  • Brazil AGU requests extension on deadline for cannabis regulations ...
  • Switzerland Bern recreational cannabis project extended ...
  • Japan Law in force today criminalises recreational and legalises medical cannabis ...
  • Germany ‘Not the second pillar’ as BMEL issues rules on cannabis research projects ...
  • France Restart of experiment on medical cannabis could be pushed to 2026 ...
  • Florida - United States Letters of intent to approve medical marijuana permits issued ...
  • Netherlands Experimental phase of controlled cannabis experiment starts 7th April ...
View all
News analysis

Cannabis & Me – critics fear bias before major psychiatric study gets under way

Written by || 20th October 2022 || News analysis | Cannabis – medical | Cannabis – recreational | Health and science | GeographiesEurope United Kingdom

A major new study into the impact of cannabis on the brain has attracted controversy and brought accusations of bias from within the industry before it even begins.

Headed by Marta Di Forti, senior clinical fellow at King’s Institute of Psychiatry, Psychology and Neuroscience, and funded by the UK Medical Research Council, Cannabis & Me will use DNA genetic and epigenetics testing, psychological and cognitive analysis, and virtual reality to explore the link between a user’s biological make-up and the effect cannabis has on an estimated 6,000 participants. But some experts have raised concerns that the results could be biased towards suggesting the potentially harmful effects of cannabis.

Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber
Author default picture

Lorraine Mullaney

Senior writer
Lorraine is responsible for writing news analysis and assisting with copy-editing. Lorraine is a copywriter and editor who has written and edited words for a wide range of audiences, from local community newspapers to consumer magazines and trade websites.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.